FR2451191A1 - Compositions therapeutiques a base de derives hydroxyles de l'isopropylamino-2 pyrimidine - Google Patents

Compositions therapeutiques a base de derives hydroxyles de l'isopropylamino-2 pyrimidine

Info

Publication number
FR2451191A1
FR2451191A1 FR8005277A FR8005277A FR2451191A1 FR 2451191 A1 FR2451191 A1 FR 2451191A1 FR 8005277 A FR8005277 A FR 8005277A FR 8005277 A FR8005277 A FR 8005277A FR 2451191 A1 FR2451191 A1 FR 2451191A1
Authority
FR
France
Prior art keywords
therapeutic compositions
isopropylamino
pyrimidine
hydroxyl derivatives
compositions based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8005277A
Other languages
English (en)
French (fr)
Other versions
FR2451191B1 (ko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ugine Kuhlmann SA
Original Assignee
Ugine Kuhlmann SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26270867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2451191(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ugine Kuhlmann SA filed Critical Ugine Kuhlmann SA
Publication of FR2451191A1 publication Critical patent/FR2451191A1/fr
Application granted granted Critical
Publication of FR2451191B1 publication Critical patent/FR2451191B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8005277A 1979-03-10 1980-03-10 Compositions therapeutiques a base de derives hydroxyles de l'isopropylamino-2 pyrimidine Granted FR2451191A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7908494 1979-03-10
GB7914987 1979-04-30

Publications (2)

Publication Number Publication Date
FR2451191A1 true FR2451191A1 (fr) 1980-10-10
FR2451191B1 FR2451191B1 (ko) 1983-04-29

Family

ID=26270867

Family Applications (2)

Application Number Title Priority Date Filing Date
FR8005278A Granted FR2451370A1 (fr) 1979-03-10 1980-03-10 Derives hydroxyles de l'isopropylamino-2 pyrimidine et leur preparation
FR8005277A Granted FR2451191A1 (fr) 1979-03-10 1980-03-10 Compositions therapeutiques a base de derives hydroxyles de l'isopropylamino-2 pyrimidine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR8005278A Granted FR2451370A1 (fr) 1979-03-10 1980-03-10 Derives hydroxyles de l'isopropylamino-2 pyrimidine et leur preparation

Country Status (24)

Country Link
JP (1) JPS55122768A (ko)
AR (1) AR222691A1 (ko)
AU (1) AU533547B2 (ko)
BE (1) BE881752A (ko)
CA (1) CA1132561A (ko)
CH (1) CH644368A5 (ko)
DE (3) DE3009071C2 (ko)
EG (1) EG14282A (ko)
FI (1) FI66357C (ko)
FR (2) FR2451370A1 (ko)
GB (1) GB2045756B (ko)
HK (1) HK55383A (ko)
IE (1) IE49547B1 (ko)
IN (1) IN153791B (ko)
LU (1) LU82185A1 (ko)
MX (1) MX6218E (ko)
MY (1) MY8400200A (ko)
NL (1) NL184833C (ko)
NO (1) NO154054C (ko)
NZ (1) NZ192927A (ko)
OA (1) OA06484A (ko)
PT (1) PT70882A (ko)
SE (1) SE435180B (ko)
SG (1) SG22683G (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE894517A (fr) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4711888A (en) 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines
WO1989000423A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US9133212B1 (en) * 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB756189A (en) * 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741667A (en) * 1952-12-05 1955-12-07 Ici Ltd New pyrimidine derivatives
ZA711152B (en) * 1970-03-02 1971-11-24 Ici Ltd Manufacture of pyrimidines
GB1525995A (en) * 1976-02-18 1978-09-27 Soc D Etudes Prod Chimique Aminopyrimidine salt

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB756189A (en) * 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives

Also Published As

Publication number Publication date
GB2045756B (en) 1983-01-26
NO154054C (no) 1986-07-09
AU533547B2 (en) 1983-12-01
NO800664L (no) 1980-09-11
CA1132561A (en) 1982-09-28
FI66357B (fi) 1984-06-29
FI66357C (fi) 1984-10-10
DE3050999C2 (de) 1986-08-14
DE3016752A1 (de) 1980-12-04
FI800566A (fi) 1980-09-11
EG14282A (en) 1983-09-30
DE3016752C2 (ko) 1987-06-25
LU82185A1 (fr) 1980-06-06
NL184833C (nl) 1989-11-16
SG22683G (en) 1983-12-16
GB2045756A (en) 1980-11-05
OA06484A (fr) 1981-07-31
FR2451370A1 (fr) 1980-10-10
SE435180B (sv) 1984-09-10
NO154054B (no) 1986-04-01
AU5624880A (en) 1980-09-18
NZ192927A (en) 1981-07-13
DE3009071A1 (de) 1980-09-11
IN153791B (ko) 1984-08-18
SE8001812L (sv) 1980-09-11
IE49547B1 (en) 1985-10-30
NL184833B (nl) 1989-06-16
MX6218E (es) 1984-12-21
AR222691A1 (es) 1981-06-15
HK55383A (en) 1983-11-25
IE800477L (en) 1980-09-10
DE3050999A1 (ko) 1985-08-14
JPS6126996B2 (ko) 1986-06-23
DE3009071C2 (de) 1985-11-14
PT70882A (en) 1980-03-01
MY8400200A (en) 1984-12-31
FR2451191B1 (ko) 1983-04-29
JPS55122768A (en) 1980-09-20
CH644368A5 (en) 1984-07-31
NL184468B (nl) 1989-03-01
NL8001289A (nl) 1980-09-12
BE881752A (fr) 1980-05-30
FR2451370B1 (ko) 1983-05-13

Similar Documents

Publication Publication Date Title
FR2451191A1 (fr) Compositions therapeutiques a base de derives hydroxyles de l'isopropylamino-2 pyrimidine
TW228515B (ko)
DK341187D0 (da) Virucidt middel med bredspekret virkning
AU1974888A (en) Glycerol and diglycerol mixtures for skin moisturising
CA2085192A1 (fr) Derives de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides
GB2210556B (en) The use of 15-keto-16-halo-prostaglandins in cathartic compositions
TNSN89103A1 (fr) [(diarylmethoxy) alcoyl]-1 pyrrolidines et piperidines et leurs procedes de preparation
FR2450820A1 (fr) Nouveaux derives d'acides 1- (o-mercaptoacyl) -4,5-dihydropyrazole-5-carboxyliques, utiles notamment comme agents hypotenseurs, et leur procede de preparation
FR2421914A1 (fr) 3-acetoxy-9b-11b-epoxy-pregna-trienes et dienes et procede de preparation de 6a-halogeno-pregna-1,4-diene-3 ones et de 6a halogeno-pregna-4-ene-3-ones correspondants
FR2447375A1 (fr) Analogues de la prostaglandine e1 et compositions pharmaceutiques les contenant
ES426040A1 (es) Procedimiento de preparacion de esteres cicloalquil-alqui- licos de acidos que tienen el esqueleto del eburnano.
FR2407203A1 (fr) Azetidinones monocycliques antibiotiques
ES2002207A6 (es) Un metodo para producir derivados de glucosilmoranolina
FR2359116A1 (fr) N-alkyldiphenylamines
FR2455588A1 (fr) Preparation des derives hydroxyles de l'isopropylamino-pyrimidine (sequence reduction hydrogene)
FR2637500A1 (fr) Medicaments a base de nouveaux derives de la carbonyl-2 n, n'-di-(trimethoxybenzoyle) piperazine
FR2433553A1 (fr) Resines de polyesters insatures, non inhibees par l'oxygene de l'air, leur preparation et leurs utilisations
Hubbard et al. Effects of pyribenzamine on the respiration of mouse brain homogenates
FR2637499A1 (fr) Medicaments a base de nouveaux derives de la methoxycarbonyl-2 n, n'-di-(trimethoxybenzoyle) piperazine
ES8304111A1 (es) Procedimiento para la preparacion de 2,3-dihidro piranos.
BE905784A (fr) Carbamoyloxymethylalcoylcarbapenemes.
BE902610A (fr) Nouvelles anthracyclines et leur procede de fabrication.
FR2429202A1 (ko)
FR2382901A1 (ko)
FR2427325A1 (fr) Derives de l'alanine possedant des proprietes fongicides, leur preparation et leurs utilisations

Legal Events

Date Code Title Description
ST Notification of lapse